Myelin News and Research

RSS

Myelin is the fatty substance that covers and protects nerves.

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

Researchers conducted cerebrospinal fluid (CSF) proteome profiling and identified CSF proteins.

17 Jul 2023

Myelin can be harmful to axons in multiple sclerosis

Multiple sclerosis (MS) is a serious neurological disease that usually causes permanent disability. Approximately 2.9 million people are affected worldwide, 240,000 in Germany alone.

30 Jun 2023

Determining the effect of estriol treatment on cerebral cortex in the preclinical model of MS

Treating a mouse model of multiple sclerosis with the pregnancy hormone estriol reversed the breakdown of myelin in the brain's cortex, a key region affected in multiple sclerosis, according to a new UCLA Health study.

16 Jun 2023

Study reveals biologically validated imaging-based evidence of medically induced myelin repair

A decade after UC San Francisco scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug's effectiveness in repairing the brain, making it possible to also assess future therapies for the devastating disorder.

13 Jun 2023

Revolution in neuroscience: 2D nanomaterials propel advances in brain repair, treatment, and diagnosis

Review discusses the increasing importance of two-dimensional nanomaterials like graphene in neuroscience, highlighting their potential in nerve repair, creating brain-mimicking synaptic devices, and treating neurological disorders. It also considers the challenges and future prospects of these materials in this complex field.

11 Jun 2023

Microparticle-delivered therapy likely to be the first step toward stopping autoimmune diseases

According to the federal government's National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide -; with almost a third in the United States -; are living with multiple sclerosis (MS), a disabling neurological disease in which the body's immune system mistakenly attacks nerves feeding information to the central nervous system (the brain and spinal cord). Although rarely fatal, MS can lead to long-term disabilities, and impair movement, muscle control, vision and cognition.

6 Jun 2023

New insights into how axons grow could lead to effective therapies for blindness, paralysis

Injuries to the nerves can blind or paralyze because adult nerve cells don't regenerate their connections. Now, a team of UConn School of Medicine researchers report in Development that at least a small population of nerve cells exist in everyone that could be coaxed to regrow, potentially restoring sight and movement.

31 May 2023

Language exposure can shape the brains of young children

Talking to toddlers helps shape their developing brain, according to new research from the University of East Anglia.

15 May 2023

Motor cortex study: effector regions alternate with somato-cognitive action network

Researchers mapped the functional organization of the motor cortex (M1) of the human brain.

24 Apr 2023

Researchers develop a backpack-based myeloid cell therapy for MS patients

Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing patients' ability to move and function to progressively decline.

21 Apr 2023

Research reveals a more effective treatment for multiple sclerosis patients

Degeneration of myelin, an insulating sheath required for rapid communication between nerve cells, and neuroinflammation are notable hallmarks of Multiple Sclerosis (MS) and related neurodegenerative disorders such as Alzheimer's disease or Huntington's disease that affect roughly 2.8 million people in the world.

21 Apr 2023

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease.

20 Apr 2023

Researcher hypothesizes that overnutrition could lead to loss of self-tolerance by impinging on immune regulation

Researchers explored the correlation between autoimmunity and obesity.

3 Apr 2023

Mea6 elimination in oligodendrocytes impairs white matter structure and lipid content

More than half amount in adult human brain is made up of white matter. Lipid-rich myelin is a special structure formed by oligodendrocytes wrapping neuronal axons to form the major components of white matter.

27 Mar 2023

Playing tackle football at an early age increases risk for brain decline later

The degenerative brain disease known as CTE, or chronic traumatic encephalopathy, has become a specter haunting football.

20 Mar 2023

Criteria to assess for multiple sclerosis in adults may be insufficient for pediatric patients

Criteria used by neurologists to assess for multiple sclerosis (MS) in adults may fail to identify the illness in children with imaging suspicious for the disease, an oversight that could delay treatment of the disease at its earliest stages, according to a Rutgers study.

16 Mar 2023

Myelin News and Research

Further Reading

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

Myelin can be harmful to axons in multiple sclerosis

Determining the effect of estriol treatment on cerebral cortex in the preclinical model of MS

Study reveals biologically validated imaging-based evidence of medically induced myelin repair

Revolution in neuroscience: 2D nanomaterials propel advances in brain repair, treatment, and diagnosis

Microparticle-delivered therapy likely to be the first step toward stopping autoimmune diseases

New insights into how axons grow could lead to effective therapies for blindness, paralysis

Language exposure can shape the brains of young children

Motor cortex study: effector regions alternate with somato-cognitive action network

Researchers develop a backpack-based myeloid cell therapy for MS patients

Research reveals a more effective treatment for multiple sclerosis patients

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

Researcher hypothesizes that overnutrition could lead to loss of self-tolerance by impinging on immune regulation

Mea6 elimination in oligodendrocytes impairs white matter structure and lipid content

Playing tackle football at an early age increases risk for brain decline later

Criteria to assess for multiple sclerosis in adults may be insufficient for pediatric patients

Study provides strong support for AAV.NT-3 gene therapy in the management of sarcopenia

An overview of COVID-19-associated neurological complications in children

Abnormally low autoantibody activity significantly associated with autism severity

Apolipoprotein E4 promotes the development of Alzheimer’s disease

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News